For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Search Posts
Op-Eds
Pew’s Parallel Universe
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> The “new biotechnology,” or gene-splicing, applied to agriculture and food production is here to…
Study
“Mad Cow”: Is the Media Milking an Overblown Threat?
Full Document Available in PDF The recent confirmation of…
Study
The Environmental Source
NOTE: A new edition of The Environmental Source has been published. The new version of this essential reference book on environmental policy is available in…
News Release
Understanding the Perils of Drug Reimportation
Washington, D.C., December 21, 2004—Today, as the Department of Health and Human Services is poised to release its pending report on drug reimportation, the Competitive…
Op-Eds
The Danger of Too Much Caution
Congress has a long and ignoble history of exaggerated legislative responses to perceived health crises. They seem to be at it again.<?xml:namespace prefix…
News Release
Disrupting Unscientific Chemical Speculation
Contact for Interviews: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Richard Morrison, 202.331.2273 …